HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tomoyuki Nishizaki Selected Research

adenosine transporter

8/2012Intracellularly transported adenosine induces apoptosis in [corrected] MCF-7 human breast cancer cells by accumulating AMID in the nucleus.
8/2010Adenosine-induced caspase-3 activation by tuning Bcl-XL/DIABLO/IAP expression in HuH-7 human hepatoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tomoyuki Nishizaki Research Topics

Disease

24Neoplasms (Cancer)
01/2016 - 04/2010
17Malignant Mesothelioma
11/2015 - 02/2010
11Stomach Neoplasms (Stomach Cancer)
12/2015 - 05/2004
9Hepatocellular Carcinoma (Hepatoma)
12/2014 - 05/2007
8Alzheimer Disease (Alzheimer's Disease)
07/2019 - 03/2008
8Necrosis
01/2016 - 07/2006
8Lung Neoplasms (Lung Cancer)
12/2014 - 01/2012
5Urinary Bladder Neoplasms (Bladder Cancer)
12/2014 - 01/2012
5Kidney Neoplasms (Kidney Cancer)
12/2014 - 01/2012
5Dementia (Dementias)
01/2011 - 12/2002
4Colonic Neoplasms (Colon Cancer)
01/2016 - 01/2009
4Prostatic Neoplasms (Prostate Cancer)
12/2014 - 01/2012
4Mesothelioma
10/2013 - 01/2012
4Cognitive Dysfunction
12/2010 - 03/2008
3Hyperplasia
03/2015 - 01/2012
3Pulmonary Fibrosis (Fibrosing Alveolitis)
10/2013 - 04/2013
3Neuroblastoma
01/2010 - 08/2003
2Breast Neoplasms (Breast Cancer)
07/2015 - 08/2012
2Mental Disorders (Mental Disorder)
04/2015 - 01/2011
2Adenocarcinoma
03/2015 - 01/2012
2Colorectal Neoplasms (Colorectal Cancer)
01/2015 - 12/2014
2Infections
11/2012 - 09/2012
2Memory Disorders (Memory Loss)
07/2012 - 02/2009
2Hyperalgesia
09/2011 - 08/2010
1Tauopathies
01/2016
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
01/2016
1Hypertension (High Blood Pressure)
03/2013

Drug/Important Bio-Agent (IBA)

17Adenosine (Adenocard)FDA LinkGeneric
10/2015 - 05/2004
10Caspase 3 (Caspase-3)IBA
01/2016 - 05/2007
10Purinergic P1 Receptors (Adenosine Receptor)IBA
01/2013 - 07/2006
8naftopidilIBA
01/2016 - 01/2012
8CaspasesIBA
11/2015 - 01/2011
8Proteins (Proteins, Gene)FDA Link
11/2012 - 05/2010
7Propidium (Propidium Iodide)IBA
01/2016 - 07/2006
61- (2- (2- methoxyphenylamino)ethylamino)- 3- (naphthalene- 1- yloxy)propan- 2- olIBA
01/2016 - 01/2013
6Annexin A5IBA
01/2016 - 07/2006
5Adenosine Triphosphate (ATP)IBA
01/2016 - 01/2010
5Caspase 9IBA
01/2016 - 07/2006
4Messenger RNA (mRNA)IBA
04/2013 - 01/2011
3Amyloid (Amyloid Fibrils)IBA
07/2019 - 03/2008
3Cholinergic ReceptorsIBA
12/2015 - 03/2003
3Adenosine DeaminaseIBA
01/2015 - 01/2010
3adenovirus receptorIBA
04/2013 - 09/2012
3Caspase 8 (Caspase-8)IBA
03/2013 - 05/2010
3AMP-Activated Protein KinasesIBA
08/2012 - 05/2004
38- (2- (2- pentyl- cyclopropylmethyl)cyclopropyl)octanoic acidIBA
07/2012 - 05/2010
3A-factor (Streptomyces)IBA
08/2010 - 08/2003
2Glycogen Synthase (Synthase I)IBA
11/2018 - 01/2016
2Phosphatidylinositols (Phosphatidylinositol)IBA
12/2015 - 01/2015
21,2- diarachidonoyl- glycero- 3- phosphoethanolamine (DAPE)IBA
11/2015 - 09/2015
2AntioxidantsIBA
11/2015 - 11/2002
2Phosphotransferases (Kinase)IBA
09/2015 - 01/2012
2Estrogen ReceptorsIBA
07/2015 - 01/2014
2human ERBB2 proteinIBA
07/2015 - 01/2014
2Irinotecan (Camptosar)FDA LinkGeneric
03/2015 - 01/2015
2Cisplatin (Platino)FDA LinkGeneric
03/2015 - 07/2014
2Paclitaxel (Taxol)FDA LinkGeneric
03/2015 - 07/2014
29-(2-hydroxy-3-nonyl)adenine (EHNA)IBA
01/2015 - 04/2010
2Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2014 - 01/2013
23- (4,5- dimethyl- 2- thiazolyl)- 2,5- diphenyl- 2H- tetrazolium bromideIBA
04/2014 - 03/2013
2DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
04/2014 - 03/2013
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2014 - 01/2012
2Antineoplastic Agents (Antineoplastics)IBA
10/2013 - 01/2012
2HMGB1 Protein (HMG1)IBA
09/2013 - 04/2013
2Prazosin (Minipress)FDA LinkGeneric
03/2013 - 01/2012
2Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
01/2013 - 01/2012
2adenosine transporterIBA
08/2012 - 08/2010
2Dipyridamole (Persantine)FDA LinkGeneric
08/2012 - 08/2010
2Platelet-Derived Growth FactorIBA
01/2012 - 02/2010
2SphingosineIBA
01/2012 - 01/2012
2Norepinephrine (Noradrenaline)FDA LinkGeneric
09/2011 - 08/2010
2Adrenergic Receptors (Adrenergic Receptor)IBA
09/2011 - 08/2010
2Glutamic Acid (Glutamate)FDA Link
03/2003 - 12/2002
1Peptides (Polypeptides)IBA
07/2019
1Interleukin-33IBA
11/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2016
1Cytochromes c (Cytochrome c)IBA
01/2016
11,2- O- bis(8- (2- (2- pentylcyclopropylmethyl)cyclopropyl)octanoyl)- sn- glycero- 3- phosphatidylethanolamineIBA
01/2016
1ElementsIBA
01/2016
1Inositol (Myoinositol)IBA
12/2015
1Conditioned Culture MediaIBA
11/2015
1NADPH Oxidases (NAD(P)H oxidase)IBA
11/2015
1p38 Mitogen-Activated Protein KinasesIBA
11/2015
1Mitochondrial Permeability Transition PoreIBA
09/2015
1Progesterone Receptors (Progesterone Receptor)IBA
07/2015
1Glycogen Synthase KinasesIBA
04/2015
1AnnexinsIBA
01/2015
1Mitogen-Activated Protein KinasesIBA
05/2014
1phosphatidylethanolamineIBA
04/2014
1tesmilifene (DPPE)IBA
04/2014
1Estrogens (Estrogen)FDA Link
01/2014
1Phenobarbital (Luminal)FDA Link
01/2014
1AsbestosIBA
10/2013
1Angiopoietin-1IBA
10/2013

Therapy/Procedure

3Drug Therapy (Chemotherapy)
10/2015 - 04/2013
3Therapeutics
01/2015 - 10/2013
1Mastectomy (Mammectomy)
07/2015
1Segmental Mastectomy (Lumpectomy)
07/2015
1Cytoreduction Surgical Procedures
09/2013
1Radiotherapy
04/2013